Healthcare provider profile · identity verified

Michael E Adams, MD

Family Practice · WARRENSBURG, NY · NPI 1518071463

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	237	107
Omeprazole	Omeprazole	165	65
Amlodipine Besylate	Amlodipine Besylate	156	57
Levothyroxine Sodium	Levothyroxine Sodium	142	49
Lisinopril	Lisinopril	99	45
Simvastatin	Simvastatin	96	41
Prednisone	Prednisone	89	80
Gabapentin	Gabapentin	80	27
Metoprolol Succinate	Metoprolol Succinate	74	34
Albuterol Sulfate Hfa	Albuterol Sulfate	73	29
Tamsulosin Hcl	Tamsulosin Hcl	71	24
Hydrochlorothiazide	Hydrochlorothiazide	65	31
Metformin Hcl	Metformin Hcl	63	33
Venlafaxine Hcl Er	Venlafaxine Hcl	63	18
Furosemide	Furosemide	61	23
Losartan Potassium	Losartan Potassium	58	24
Pantoprazole Sodium	Pantoprazole Sodium	51	16
Duloxetine Hcl	Duloxetine Hcl	48	17
Rosuvastatin Calcium	Rosuvastatin Calcium	45	17
Eliquis	Apixaban	42	16
Amitriptyline Hcl	Amitriptyline Hcl	41	11
Fluticasone Propionate	Fluticasone Propionate	41	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	39
Potassium Chloride	Potassium Chloride	40	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	14
Trazodone Hcl	Trazodone Hcl	36	14
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	33
Allopurinol	Allopurinol	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	13
Metformin Hcl Er	Metformin Hcl	29	12
Jardiance	Empagliflozin	28	12
Paroxetine Hcl	Paroxetine Hcl	28	11
Clopidogrel	Clopidogrel Bisulfate	27	13
Escitalopram Oxalate	Escitalopram Oxalate	27	11
Enalapril Maleate	Enalapril Maleate	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Sertraline Hcl	Sertraline Hcl	24	13
Celecoxib	Celecoxib	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Cephalexin	Cephalexin	20	20
Famotidine	Famotidine	20	suppressed
Alprazolam	Alprazolam	19	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	11
Montelukast Sodium	Montelukast Sodium	19	11
Irbesartan	Irbesartan	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ozempic	Semaglutide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Diazepam	Diazepam	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Amoxicillin	Amoxicillin	13	13
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Finasteride	Finasteride	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Colchicine	Colchicine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Azithromycin	Azithromycin	11	11
Buspirone Hcl	Buspirone Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error